Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration

Article ID	Journal	Published Year	Pages	File Type
5587500	Frontiers in Neuroendocrinology	2016	16 Pages	PDF

Keywords

PPAR-γ G protein-coupled estrogen receptor 1 ACEIs AT2 AT1 DPN ovariectomized OVX AII VTA MPTP IL-1β ER-α RNS RAS SNC 6-Hydroxydopamine HRT 6-OHDA PPT ACE 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 17-β-estradiol ROS angiotensin converting enzyme angiotensin Angiotensin II Women’s Health Initiative Estrogens Neuroinflammation Interleukin-1β Parkinson’s disease Oxidative stress Neurodegeneration estrogen replacement therapy hormonal replacement therapy CNS Dopamine Rho kinase renin-angiotensin system central nervous system Substantia nigra compacta Neuroprotection ACE inhibitors ventral tegmental area ERT Hormonal therapy whi Parkinson Peroxisome proliferator-activated receptor gamma reactive nitrogen species Reactive oxygen species Estrogen receptor Estrogen receptor-α Rock Menopause

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Endocrinology

Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration

Authors

Jose L. Labandeira-Garcia, Ana I. Rodriguez-Perez, Rita Valenzuela, Maria A. Costa-Besada, Maria J. Guerra,